A randomized, placebo controlled trial of prostacyclin (PGI2) in peripheral arterial disease
- 1 May 1981
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 22 (4) , 481-490
- https://doi.org/10.1016/0049-3848(81)90109-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- INTRAVENOUS PROSTACYCLIN FOR ISCHAEMIC ULCERS IN PERIPHERAL ARTERY DISEASEThe Lancet, 1980
- Prostacyclin therapy in peripheral arterial diseaseThrombosis Research, 1980
- A double blind placebo controlled crossover study of prostacyclin in manLife Sciences, 1979
- Prostacyclin-dependent differences in TXA2 formation by platelets from normal and atherosclerotic rabbitsAtherosclerosis, 1979
- SUCCESSFUL THERAPY OF ADVANCED ARTERIOSCLEROSIS OBLITERANS WITH PROSTACYCLINThe Lancet, 1979
- VASCULAR PROSTACYCLIN MAY BE REDUCED IN DIABETES IN MANThe Lancet, 1979
- Decreased vascular prostacyclin in experimental diabetesLife Sciences, 1978
- The generation of prostacyclin by arteries and by the coronary vascular bed is reduced in experimental atherosclerosis in rabbitsProstaglandins, 1977
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- On the Measurement of Spontaneous Platelet Aggregation. The Platelet Aggregation Test III.Thrombosis and Haemostasis, 1976